[Federal Register Volume 68, Number 186 (Thursday, September 25, 2003)]
[Notices]
[Pages 55393-55394]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-24275]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-03-120]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer at (404) 498-1210.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Anne O'Connor, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.
    Proposed Project: Survey of Primary Care Physicians Regarding 
Prostate Cancer Screening--New--National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control 
and Prevention (CDC).
    Prostate cancer is the most common cancer in men and is the second 
leading cause of cancer deaths, behind lung cancer. The American Cancer 
Society estimates that there will be about 220,900 new cases of 
prostate cancer and about 28,900 deaths in 2003. Although prostate 
cancer deaths have declined over the past several years, it ranks fifth 
among deaths from all causes. The digital rectal examination (DRE) and 
prostate specific antigen (PSA) test are used to screen for prostate 
cancer. Screening is controversial and many are not in agreement as to 
whether prostate specific antigen (PSA) based screening, early 
detection, and later treatment increases longevity. Although major 
medical organizations are divided on whether men should be routinely 
screened for this disease, it appears that all of the major 
organizations recommend discussion with patients about the benefits and 
risks of screening.
    The purpose of this project is to develop and administer a national 
survey to a sample of American primary care physicians to examine 
whether or not they: screen for prostate cancer using (PSA and/or DRE), 
recommend testing and under what conditions, discuss the tests and the 
risks and benefits of screening with patients, and if their screening 
practices vary by factors such as age, ethnicity, and family history. 
This study will examine demographic, social, and behavioral 
characteristics of physicians as they relate to screening and related 
issues, including knowledge and awareness, beliefs regarding efficacy 
of screening and treatment, frequency of screening, awareness of the 
screening controversy, influence of guidelines from medical, practice 
and other organizations, and participation and/or willingness to 
participate in shared decision-making. There is no cost to respondents.

----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of        burden/      Total  burden
                   Respondents                      respondents     responses/     response  (in    (in hours)
                                                                    respondents       hours)
----------------------------------------------------------------------------------------------------------------
Primary Care Physician..........................           1,500               1           40/60           1,000
                                                 -----------------
    Total.......................................  ..............  ..............  ..............           1,000
----------------------------------------------------------------------------------------------------------------



[[Page 55394]]

    Dated: September 19, 2003.
Thomas A. Bartenfeld,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 03-24275 Filed 9-24-03; 8:45 am]
BILLING CODE 4163-18-P